awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40971388-DC921E0F-605F-423F-8E37-A53702567081
Q40971388-DC921E0F-605F-423F-8E37-A53702567081
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40971388-DC921E0F-605F-423F-8E37-A53702567081
A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia.
P2860
Q40971388-DC921E0F-605F-423F-8E37-A53702567081
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40971388-DC921E0F-605F-423F-8E37-A53702567081
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fdfca20d5f38d53f55ee42a19d16dc2ff57c7ee5
P2860
A dose-escalation study of SAR3419, an anti-CD19 antibody maytansinoid conjugate, administered by intravenous infusion once weekly in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.